Nihon M&A Center (2127) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
1 Sep, 2026Executive summary
Q1 FY2026/FY2027 sales rose 0.9% year-over-year to ¥9,104 million, with 188 transactions closed, down 11.3%, but higher M&A sales per transaction offset declines.
Extraordinary gain of approximately ¥800 million from AtoG Capital contributed significantly to pre-tax profit.
Leading indicators, such as new mandates and transactions under negotiation, reached record highs, supporting a positive outlook.
Profit attributable to owners of parent rose 33.8% year-over-year to ¥2,027 million; comprehensive income increased 71.2%.
Financial highlights
Sales: ¥9,104 million (+0.9% YoY); M&A sales per transaction: ¥46.3 million (+13.4% YoY).
Ordinary profit: ¥2,252 million (-11.1% YoY); pre-tax profit: ¥3,156 million (+24.6% YoY, boosted by extraordinary gain).
Net profit: ¥2,206 million (+46.5% YoY); profit attributable to parent: ¥2,027 million (+33.8% YoY).
Interim fee received in Q1: ¥1,358 million (+17% YoY).
Basic earnings per share for the quarter were ¥6.39, up from ¥4.78 in the prior year.
Outlook and guidance
Full-year net sales forecast for FY ending March 31, 2027, is ¥52,800 million (+5.1% YoY); operating profit projected at ¥19,300 million (+2.9% YoY).
Ordinary profit target for FY2032 set at ¥30 billion, with business domain expansion in fund, overseas, and PMI businesses.
Confident in achieving first-half and full-year targets, supported by robust leading indicators and new mandates.
Dividend per share forecast maintained at ¥29, with a payout ratio above 60%.
Latest events from Nihon M&A Center
- Record-high profits, global expansion, and robust compliance drive sustainable growth.2127
AGM 2026 - Double-digit profit and sales growth, with strong FY2026 outlook and stable dividends.2127
Q4 2026 - Record sales, profits, and margins drive positive outlook and special dividend.2127
Q3 2026 - H1 FY2025 saw strong profit and sales growth, margin gains, and a special dividend planned.2127
Q2 2026 - Q1 sales and profits surged, margins improved, and guidance remains strong with a special dividend.2127
Q1 2026 - Record new mandates and strong profit margins support growth despite industry challenges.2127
Q2 2025 - Q1 sales and profits fell, but strong mandates and investments support a positive outlook.2127
Q1 2025 - Record Q4 profit and new mandates highlight resilience and cautious outlook.2127
Q4 2025 - Sales and profit fell, but record new mandates and strong forecasts signal future growth.2127
Q3 2025